3997. Misbranding of Panrein tablets, Panbile tablets, Ioaquasol tablets, Noodor tablets, Nokof tablets, and Thiekla. U. S. v. 3 Bottles, etc (F. D. C. No. 34651. Sample Nos. 46652-L to 46655-L, incl., 46657-L, 46658^-L.) LIBEL FILED : February 9, 1953, Southern District of Texas. ALLEGED SHIPMENT: On various dates during the latter part of 1952 and the early part of 1953, by John C. Thie (TPCS Distributors), from Pasadena, Calif. PRODUCT: 3 90-tablet bottles of Panrein tablets, 3 90-tablet bottles of Pan- bile tablets, 4 90-tablet bottles of Ioaquasol tablets, 3 90-tablet bottles of Noodor tablets, 2 40-tablet bottles of Nokof tablets, and 4 2-ounce jars of Thiekla at Houston, Tex., together wtih an accompanying booklet entitled "A New Approach to Therapy [Anat]." LABEL, IN PAST: (Bottle) "Formula I Panrein 90 tablets (1-wv) Each Tablet Contains: Barosma 65.0 Mg. Bear Berry 64.4 Mg. Couch Grass 66.2 Mg. Alfalfa 63.6 Mg. In a base of parsley and other inert filler," "Formula III Panbile 90 Tablets (3-WW) Each Enteric coated tablet contains: Pancreatin USP 259.2 Mg. Bile Salts (Ext. Ox Bile) 129.6 Mg. Dehy- drocholic Acid 21.6 Mg. In desiccated protein and other excipients," "Formula 2 Ioaquasol 90 Tablets (2 WV) Each enteric coated tablet contains: Iodine 30.2 mg. Combined and proportioned by a special process making a water soluble iodine compound-Ioaquasol," "Formula XVII Noodor 90 Tablets (17-2W) Each tablet contains excipients and Chloro- phyll which are completely water soluble," "Formula XXV Nokof 40 Tablets (25-W) Each tablet Contains: P. E. Licorice Root 32 mg., ester of Para- Amino-Benzoic acid 12 mg. (one of the Vitamin B Complex Factors) ; in a base containing Peppermint (ext.), Anise, and excipients," and (jar) "Formula V Thiekla (5-W) Contains: Oxides, Chlorides, Sulphates, Nitrates, and Carbonates, of Ca, Fe, Mg, Na, K, H, N, I, and other Colloidal minerals normally found in the human body." NATURE OF CHARGE: Misbranding, Section 502 (a), certain statements in the above-mentioned booklet were false and misleading since the articles were not adequate and effective treatments for the conditions and purposes repre- sented and suggested. The statements represented and suggested : That the Panrein tablets were an adequate and effective treatment for im- proving health, stopping the death process, maintaining normal health, dropsy, inflamed condition of the urinary organs, nervousness, irritable bladder, cys- titis, diseases of the urinary tract, gravel, chronic catarrh of the bladder, morbid irritation of the bladder and urethra, diseases of the prostate, urinary ?See also Nos. 3981, 3985, 39S6, 398S, 3.989, 3&&2-39S6. incontinence, kidney complaint, chronic nephritis, ulceration of the urinary organs, bladder catarrh, gleet, leucorrhea, menorrhagia, and uremic poisoning; That the PanMle tablets were an adequate and effective treatment for di- gestive disorders, maintaining normal health, enabling one to be more re- freshed with less sleep, and causing one to feel better generally; That the Ioaquasol tablets were an adequate and effective treatment for maintaining normal health, normalizing the metabolism, providing "pick-up," "looked-for-relief," and "lift," coarse nails, rough, dry, and scaly skin, skin eruptions, sterility, lowered physical energy, impaired mental faculties, irritability, nervousness, rapid pulse, irregular pulse, poor digestion, decreased liver function, emaciation, obesity, myxedema, increased tendency to in- fection, inhibited development of children, low basal metabolism rate, sudden gain or loss of weight, serous accumulation, skin rash, bronchial cough, eye dryness, improper functioning of the glands, especially the thyroid, excessive mucus secretions, enlargement of the glands such as the prostate, difficult respiration, nerve pressure, tendency to malignancy, toxicity, cell exhaustion, arthritis, rheumatism, asthma, allergies, angioneurotic edema, arteriosclerosis, maternal deficiencies causing stillbirth, reduced flow of endosecretions, low icterus index, fungus infections, trichomonas vaginitis, ringworm, malnutrition, acute infectious diseases, fevers, glandular enlargement, chronic colds, eczema, and rheumatic fever; That the Noodor tablets were an adequate and effective treatment for stimu- lating contractility of heart tissue, preserving heart tissue, dilating small arteries, increasing respiratory volume, decreasing the effect of fatigue of nerve and muscle tissues, increasing nitrogen metabolism, increasing hemo- globin and number of erythrocytes, increasing polymorphonuclear leucocytes, and increasing effectiveness of hormone and glandular extracts: That the Nokof tablets were an adequate and effective treatment for gastric ulcers, sore throat, laryngitis, and bronchitis; That the Thiehla was an adequate and effective treatment for internal pollution, congestions, growths, pus accumulations, local and internal in- fections, internal conditions which fail to respond to any other therapy, toxic substances, sores, pains of the chest and stomach, headaches, intestinal cramps, weakness of the back, lumbago, spinal weakness, inflammations, red blotches, small sores, red nose, palpitations of the heart, ulcers, and sprains. Further misbranding, Section 502 (e) (2), the Nokof tablets contained benzocaine, and the label failed to bear the common or usual name of the active ingredient. The libel also alleged that another product was adulterated and misbranded under the provisions of the law applicable to foods, as reported in notices of judgment on foods. DISPOSITION : March 27, 1953. Default decree of condemnation and destruc- tion.